Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.
Complications
Newborn screening
Pain crisis
Sickle cell disease
Journal
Blood cells, molecules & diseases
ISSN: 1096-0961
Titre abrégé: Blood Cells Mol Dis
Pays: United States
ID NLM: 9509932
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
30
08
2020
revised:
18
10
2020
accepted:
08
12
2020
pubmed:
6
1
2021
medline:
7
8
2021
entrez:
5
1
2021
Statut:
ppublish
Résumé
Pain is a hallmark of Sickle Cell Disease (SCD) affecting patients throughout their life; the first pain crisis may occur at any age and is often the first presentation of the disease. Universal newborn screening identifies children with SCD at birth, significantly improving morbidity and mortality. Without early screening, diagnosis is generally made after disease manifestations appear. The Consortium for the Advancement of Sickle Cell Research (CASiRe) is an international collaborative group evaluating the clinical severity of subjects with SCD using a validated questionnaire and medical chart review, standardized across 4 countries (United States, United Kingdom, Italy and Ghana). We investigated the age of first pain crisis in 555 sickle cell subjects, 344 adults and 211 children. Median age of the first crisis in the whole group was 4 years old, 5 years old among adults and 2 years old among children. Patients from the United States generally reported the first crisis earlier than Ghanaians. Experiencing the first pain crisis early in life correlated with the genotype and disease severity. Early recognition of the first pain crisis could be useful to guide counseling and management of the disease.
Identifiants
pubmed: 33401140
pii: S1079-9796(20)30568-4
doi: 10.1016/j.bcmd.2020.102531
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
102531Subventions
Organisme : NIMHD NIH HHS
ID : T37 MD001425
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.